Hill AVS - Search Results

1

Identification of antigens presented by MHC for vaccines against tuberculosis.

Bettencourt P, Müller J, Nicastri A, Cantillon D, Madhavan M, Charles PD, Fotso CB, Wittenberg R, Bull N, Pinpathomrat N, Waddell SJ, Stylianou E, Hill AVS, Ternette N, McShane H. Bettencourt P, et al. Among authors: hill avs. NPJ Vaccines. 2020 Jan 3;5(1):2. doi: 10.1038/s41541-019-0148-y. eCollection 2020. NPJ Vaccines. 2020. PMID: 31908851 Free PMC article.

2

Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A.

McShane H, Behboudi S, Goonetilleke N, Brookes R, Hill AV. McShane H, et al. Infect Immun. 2002 Mar;70(3):1623-6. doi: 10.1128/IAI.70.3.1623-1626.2002. Infect Immun. 2002. PMID: 11854254 Free PMC article.

3

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.

Goonetilleke NP, McShane H, Hannan CM, Anderson RJ, Brookes RH, Hill AV. Goonetilleke NP, et al. J Immunol. 2003 Aug 1;171(3):1602-9. doi: 10.4049/jimmunol.171.3.1602. J Immunol. 2003. PMID: 12874255

4

CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages.

Brookes RH, Pathan AA, McShane H, Hensmann M, Price DA, Hill AV. Brookes RH, et al. Eur J Immunol. 2003 Dec;33(12):3293-302. doi: 10.1002/eji.200324109. Eur J Immunol. 2003. PMID: 14635037 Free article.

5

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, Fletcher HA, Hill AV. McShane H, et al. Nat Med. 2004 Nov;10(11):1240-4. doi: 10.1038/nm1128. Epub 2004 Oct 24. Nat Med. 2004. PMID: 15502839 Clinical Trial.

6

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.

McShane H, Pathan AA, Sander CR, Goonetilleke NP, Fletcher HA, Hill AV. McShane H, et al. Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):47-52. doi: 10.1016/j.tube.2004.09.015. Epub 2005 Jan 21. Tuberculosis (Edinb). 2005. PMID: 15687027 Review.

7

Prime-boost immunisation strategies for tuberculosis.

McShane H, Hill A. McShane H, et al. Microbes Infect. 2005 May;7(5-6):962-7. doi: 10.1016/j.micinf.2005.03.009. Epub 2005 Apr 15. Microbes Infect. 2005. PMID: 15890555 Free article. Review.

8

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.

Gilbert SC, Moorthy VS, Andrews L, Pathan AA, McConkey SJ, Vuola JM, Keating SM, Berthoud T, Webster D, McShane H, Hill AV. Gilbert SC, et al. Vaccine. 2006 May 22;24(21):4554-61. doi: 10.1016/j.vaccine.2005.08.048. Epub 2005 Aug 24. Vaccine. 2006. PMID: 16150517 Review.

9

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.

Pathan AA, Sander CR, Fletcher HA, Poulton I, Alder NC, Beveridge NE, Whelan KT, Hill AV, McShane H. Pathan AA, et al. PLoS One. 2007 Oct 24;2(10):e1052. doi: 10.1371/journal.pone.0001052. PLoS One. 2007. PMID: 17957238 Free PMC article. Clinical Trial.

10

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.

Fletcher HA, Pathan AA, Berthoud TK, Dunachie SJ, Whelan KT, Alder NC, Sander CR, Hill AV, McShane H. Fletcher HA, et al. Vaccine. 2008 Sep 26;26(41):5269-75. doi: 10.1016/j.vaccine.2008.07.040. Epub 2008 Aug 3. Vaccine. 2008. PMID: 18682270 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

460 results

Search Page